尿路感染症に対するbalofloxacinの臨床的検討

書誌事項

タイトル別名
  • The clinical effects of balofloxacin on urinary tract infectious diseases

この論文をさがす

抄録

A newly developed quinolone synthetic antimicrobial drug, balofloxacin (BLFX), was administered to 21 patients with bacterial infectious diseases in the field of urology, and its efficacy and safety were investigated.<BR>Among these patients, 5 with simple cystitis and 9 with complicated urinary tract infectious disease showed results that were consistent with the criteria proposed by the Japanese UTI Committee. Overall clinical efficacy for simple cystitis was rated excellent in 2 and effective in 3. Overall clinical efficacy for complicated urinary tract infection was excellent in 2 and effective in 4. Headache was observed as a subjective side effect probably attributable to the drug in one patient. Elevation of the monocyte count was observed as an abnormal change in clinical laboratory test values in one patient.

収録刊行物

参考文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ